(MedPage Today) — NEW YORK CITY — The newer Navitor looked increasingly viable as a transcatheter aortic valve replacement (TAVR) system, based on its largest report of commercial use to date.
In the U.S., the Navitor Vision was associated…
Source link : https://www.medpagetoday.com/meetingcoverage/nyv/116248
Author :
Publish date : 2025-06-25 19:15:00
Copyright for syndicated content belongs to the linked Source.
